Cerus | CERS - Gewinn Vor Steuern





Gewinn Vor Steuern Veränderung Datum
Cerus USD -20.76M 17.9M 2024-12
GRIFOLS EUR 190.51M 20.03M 2025-06
Haemonetics USD 59.97M 8.69M 2025-12
Neogen USD 28M 15.81M 2025-09
OraSure Technologies USD -18.43M 5.14M 2025-12
Plus Therapeutics USD -5.71M 1.29M 2025-12
Quidel USD -79.5M 32.9M 2026-03
Rockwell Medical USD 343K 2.07M 2024-06
STAAR Surgical USD -20.65M 39.44M 2025-12
Terumo JPY 31.67B 13.71B 2026-03
Utah Medical Products 418K 3K 2024-09